Kinsella Matthew John 4

4 · Churchill Capital Corp X/Cayman · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Infleqtion (INFQ) CEO Matthew Kinsella Receives Awards

What Happened
Matthew J. Kinsella, CEO of Infleqtion, Inc. (formerly Churchill Capital Corp X, ticker INFQ), was granted multiple awards on Feb 13, 2026 in connection with the closing of the merger with ColdQuanta. The filing reports the acquisition of 1,178,676 shares issued at $0.00 and derivative/option-based rights covering 7,840,209 shares (total ≈ 9,018,885 shares/rights). These awards were issued pursuant to the merger agreement and include a mix of direct equity and converted legacy stock options/awards.

Key Details

  • Transaction date: Feb 13, 2026; Form 4 filed Feb 18, 2026 (timely given Feb 16 was a federal holiday).
  • Grants reported as: multiple A (award/acquisition) entries — some shares reported at $0.00 (direct shares) and others reported as derivative awards (N/A for price/value).
  • Counts: 560,327; 34,740; 101,882; 481,727 shares (issued at $0.00); plus derivative amounts of 5,950,380 and 1,889,829 (N/A). Total ≈ 9,018,885 shares/rights.
  • Holdings after transaction: not specified in the summary fields of the filing.
  • Notable footnotes:
    • F1: Grants received pursuant to the Agreement and Plan of Merger and Reorganization (ColdQuanta merger).
    • F5–F8/F6: Legacy ColdQuanta stock options were converted into Issuer options with the same terms; some options vested/accelerated on closing (2,275,146 shares accelerated and vested per F5); some awards are fully vested (F7) and some vest monthly beginning Feb 17, 2026 (F8).
    • F2–F4: Portions are held by entities/trusts (Kinsella Investment Holdings, LLC and family trusts) of which Mr. Kinsella is a trustee or has voting/investment power—he may be deemed to beneficially own those shares.

Context
These grants were merger consideration and converted legacy option awards, not open-market purchases or sales. Several option-based awards were accelerated or remain subject to continued service-based vesting schedules; some awards are fully vested. Awards received in mergers are common for executives as part of deal consideration and do not, by themselves, indicate the insider's personal buying or selling intent.

Insider Transaction Report

Form 4
Period: 2026-02-13
Kinsella Matthew John
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-02-13+560,327560,327 total(indirect: See footnote)
  • Award

    Common Stock

    [F1][F3]
    2026-02-13+34,74034,740 total(indirect: See footnote)
  • Award

    Common Stock

    [F1][F4]
    2026-02-13+101,882101,882 total(indirect: See footnote)
  • Award

    Stock Option (Right to Buy)

    [F1][F6][F5]
    2026-02-13+5,950,3805,950,380 total
    Exercise: $0.90Exp: 2034-06-05Common Stock (5,950,380 underlying)
  • Award

    Stock Option (Right to Buy)

    [F1][F6][F7][F2]
    2026-02-13+1,889,8291,889,829 total(indirect: See footnote)
    Exercise: $0.90Exp: 2034-06-05Common Stock (1,889,829 underlying)
  • Award

    Stock Option (Right to Buy)

    [F8]
    2026-02-13+481,727481,727 total
    Exercise: $13.22Exp: 2036-02-12Common Stock (481,727 underlying)
Footnotes (8)
  • [F1]Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
  • [F2]Held directly by Kinsella Investment Holdings, LLC. Mr. Kinsella may be deemed to beneficially own shares of Kinsella Investment Holdings, LLC by virtue of his voting power and investment power over such shares.
  • [F3]Held directly by The John R. Kinsella Children's Trust, of which the Reporting Person is co-trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Children's Trust by virtue of his voting power and investment power over such shares.
  • [F4]Held directly by The John R. Kinsella Revocable Living Trust, of which the Reporting Person is a trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Revocable Living Trust by virtue of his voting power and investment power over such shares.
  • [F5]25% of the stock option vested and became exercisable on April 5, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. 2,275,146 of such shares accelerated and vested upon the closing of the Mergers. The option may be early exercised by the Reporting Person.
  • [F6]Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.
  • [F7]Fully vested.
  • [F8]1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date.
Signature
/s/ Jason D. Hall, Attorney-in-Fact|2026-02-18

Documents

1 file
  • 4
    form4-02182026_010217.xmlPrimary